Shares of Eli Lilly & Co. and Novo Nordisk A/S fell after US regulators established a “green list” of foreign manufacturers who produce raw materials that compounding pharmacies use to make copies of their blockbuster GLP-1 drugs.
www.bloomberg.com
#Lilly #Novo #Sink #FDA #List #Foreign #GLP1 #Ingredient #Makers
Lilly, Novo Sink on FDA List of Foreign GLP-1 Ingredient Makers
